Skip to main content
Apollo Global ManagementNews

Johnson & Johnson Stock: Apollo Offers 20 Billion

What happened

Apollo Global Management is negotiating to acquire Johnson & Johnson's orthopedics division, DePuy Synthes, for nearly $20 billion.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Johnson & Johnson could soon divest its orthopedics division DePuy Synthes - not via an IPO, but through a multi-billion dollar sale to a financial investor. According to a report, Apollo Global Management is negotiating an acquisition of the business at a valuation of almost 20 billion Dollars. A deal could be concluded within a few weeks.That DePuy Synthes is leaving the group is no surprise. J&J had already announced the spin-off in October 2025, as part of a broader portfolio realignment towards higher-growth healthcare segments. CFO Joseph Wolk confirmed in July that various separation options were being explored to create shareholder value. Originally, a timeframe of 18 to 24 months for a spin-off as an independent publicly listed company was discussed, with a target completion by mid-2027. Now an alternative is emerging: the direct sale to private equity. Several financial investors are said to have expressed interest in the business, so another bidder could still emerge.For Apollo, the transaction would be its largest healthcare investment to date and a significant expansion in the medical technology sector. Bloomberg Intelligence's in-house analysis even assumes a higher value - approximately 28 billion Dollars including debt, noticeably above the currently discussed sum. The spread between the rumored 20 billion Dollars and the higher analyst estimate shows: There...

Keep reading with a free account

The rest of this article, and every signal for Apollo Global Management, is in your free account.

Extracted by Autobound

From the Signal API record
Event
News

What this signalsIntegration work after a deal often opens needs for new systems and services.

Amount named
$20B

Companies

  • DePuy SynthesTargetdepuysynthes.com

The full record

From the Signal API record

Numbers

Amount named in the story
$20B

Extraction

Confidence
90%
Detected
Sep 12, 2026
signal_type
news
signal_subtype
acquires

Use this data

Get every news signal for Apollo Global Management and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Apollo Global Management this week?”

  2. Send it to your own tools

    The Signal API returns news signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/695a03be-cb27-4b3a-80c4-67d28e889cde returns this record as JSON. POST /v1/companies/enrich returns every signal for apollo.com.

{
  "signal_id": "695a03be-cb27-4b3a-80c4-67d28e889cde",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-09-12T00:04:11+00:00",
  "company": {
    "name": "Apollo Global Management",
    "domain": "apollo.com"
  },
  "data": {
    "url": "https://www.boerse-express.com/news/articles/johnson-johnson-aktie-apollo-bietet-20-milliarden-946596",
    "title": "Johnson & Johnson Stock: Apollo Offers 20 Billion - Börse Express",
    "excerpt": "Johnson & Johnson could soon divest its orthopedics division DePuy Synthes - not via an IPO, but through a multi-billion dollar sale to a financial investor. According to a report, Apollo Global Management is negotiating an acquisition of the business at a valuation of almost 20 billion Dollars. A deal could be concluded within a few weeks.That DePuy Synthes is leaving the group is no surprise. J&J had already announced the spin-off in October 2025, as part of a broader portfolio realignment towards higher-growth healthcare segments. CFO Joseph Wolk confirmed in July that various separation options were being explored to create shareholder value. Originally, a timeframe of 18 to 24 months for a spin-off as an independent publicly listed company was discussed, with a target completion by mid-2027. Now an alternative is emerging: the direct sale to private equity. Several financial investors are said to have expressed interest in the business, so another bidder could still emerge.For Apollo, the transaction would be its largest healthcare investment to date and a significant expansion in the medical technology sector. Bloomberg Intelligence's in-house analysis even assumes a higher value - approximately 28 billion Dollars including debt, noticeably above the currently discussed sum. The spread between the rumored 20 billion Dollars and the higher analyst estimate shows: There is...",
    "summary": "Apollo Global Management is negotiating to acquire Johnson & Johnson's orthopedics division, DePuy Synthes, for nearly $20 billion.",
    "planning": true,
    "image_url": "https://www.boerse-express.com/assets/8224e556a5/johnson-johnson-aktie-apollo-bietet-20-milliarden-946596__FillWzE5MjAsMTA4MF0.jpg",
    "confidence": 0.9,
    "published_at": "2026-09-12T00:04:11Z",
    "article_sentence": "According to a report, Apollo Global Management is negotiating an acquisition of the business at a valuation of almost 20 billion Dollars.",
    "amount_normalized": 20000000000,
    "related_company_name": "DePuy Synthes",
    "related_company_domain": "depuysynthes.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.